A Randomized Phase II Trial of Two Different Schedules of Mitomycin C and Vinorelbine in Pretreated Breast Cancer

M. Colleoni; P. Manente; J. Stocker; H. Amor; S. Lamon; P. Nelli; G. Vicario; G. Sgarbossa; C. Graiff

doi:10.1159/000227731

A Randomized Phase II Trial of Two Different Schedules of Mitomycin C and Vinorelbine in Pretreated Breast Cancer

Oncology ◽

10.1159/000227731 ◽

1997 ◽

Vol 54 (5) ◽

pp. 438-439 ◽

Cited By ~ 2

Author(s):

M. Colleoni ◽

P. Manente ◽

J. Stocker ◽

H. Amor ◽

S. Lamon ◽

...

Keyword(s):

Breast Cancer ◽

Mitomycin C ◽

Phase Ii ◽

Phase Ii Trial ◽

Randomized Phase Ii

Download Full-text

84TiP Neo-CheckRay: Radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer: A randomized phase II trial

Annals of Oncology ◽

10.1016/j.annonc.2020.10.571 ◽

2020 ◽

Vol 31 ◽

pp. S1451

Author(s):

A. De Caluwe ◽

L. Buisseret ◽

P. Poortmans ◽

C. Sotiriou ◽

D. Larsimont ◽

...

Keyword(s):

Breast Cancer ◽

Radiation Therapy ◽

Phase Ii ◽

Phase Ii Trial ◽

Early Stage ◽

Luminal B ◽

Randomized Phase Ii

Download Full-text

A phase II trial of mitomycin C, 5'-deoxy-5-fluorouridine, etoposide and medroxyprogesterone acetate (McVD-MPA) as a salvage chemotherapy to anthracycline-resistant tumor in relapsed breast cancer and its mechanism(s) of antitumor action

Oncology Reports ◽

10.3892/or.8.3.597 ◽

2001 ◽

Author(s):

R. Kim ◽

A. Osaki ◽

K. Tanabe ◽

J. Kojima ◽

T. Toge

Keyword(s):

Breast Cancer ◽

Mitomycin C ◽

Phase Ii ◽

Medroxyprogesterone Acetate ◽

Phase Ii Trial ◽

Salvage Chemotherapy ◽

Antitumor Action

Download Full-text

Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial

Annals of Oncology ◽

10.1093/annonc/mdy211 ◽

2018 ◽

Vol 29 (8) ◽

pp. 1777-1783 ◽

Cited By ~ 26

Author(s):

M. Ignatiadis ◽

S. Litière ◽

F. Rothe ◽

S. Riethdorf ◽

C. Proudhon ◽

...

Keyword(s):

Breast Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Early Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Randomized Phase Ii

Download Full-text

Randomized Phase II Trial of Weekly vs. Every 2 Weeks vs. Every 3 Weeks Nanoparticle Albumin-Bound Paclitaxel With Bevacizumab as First-Line Chemotherapy for Metastatic Breast Cancer

Clinical Breast Cancer ◽

10.1016/j.clbc.2013.02.008 ◽

2013 ◽

Vol 13 (4) ◽

pp. 239-246.e1 ◽

Cited By ~ 19

Author(s):

Andrew D. Seidman ◽

Alison K. Conlin ◽

Ariadne Bach ◽

Mary Ellen Moynahan ◽

Diana Lake ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

Randomized Phase Ii ◽

Line Chemotherapy

Download Full-text

A randomized phase II trial of MOVING ON: An intervention to increase exercise outcome expectations among breast cancer survivors

Psycho-Oncology ◽

10.1002/pon.4849 ◽

2018 ◽

Vol 27 (10) ◽

pp. 2450-2457 ◽

Cited By ~ 2

Author(s):

Rachel Hirschey ◽

Gretchen Kimmick ◽

Marilyn Hockenberry ◽

Ryan Shaw ◽

Wei Pan ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Survivors ◽

Phase Ii ◽

Breast Cancer Survivors ◽

Phase Ii Trial ◽

Outcome Expectations ◽

Randomized Phase Ii

Download Full-text

Abstract OT3-3-08: Eribulin/Cyclophosphamide versus Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Locally Advanced HER2-Negative Breast Cancer: A Randomized Phase II Trial of the Sarah Cannon Research Institute

10.1158/0008-5472.sabcs12-ot3-3-08 ◽

2012 ◽

Author(s):

DA Yardley ◽

JD Hainsworth ◽

M Shastry ◽

L Finney ◽

HA Burris

Keyword(s):

Breast Cancer ◽

Neoadjuvant Therapy ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Randomized Phase Ii ◽

Research Institute

Download Full-text

Results of randomized phase II trial combining Iressa® (gefitinib) and arimidex in women with advanced breast cancer (ABC). EORTC protocol 10021.

10.1158/0008-5472.sabcs-6133 ◽

2009 ◽

Cited By ~ 4

Author(s):

L Mauriac ◽

D Cameron ◽

L Dirix ◽

E Blot ◽

M Piccart ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Breast ◽

Randomized Phase Ii

Download Full-text

PD01-01: Randomized Phase II Trial of Fulvestrant with or without Dasatinib in Postmenopausal Patients with Hormone Receptor-Positive Metastatic Breast Cancer Previously Treated with an Aromatase Inhibitor.

10.1158/0008-5472.sabcs11-pd01-01 ◽

2011 ◽

Cited By ~ 6

Author(s):

GL Wright ◽

J Blum ◽

LK Krekow ◽

KJ McIntyre ◽

ST Wilks ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Aromatase Inhibitor ◽

Phase Ii ◽

Hormone Receptor ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Hormone Receptor Positive ◽

Randomized Phase Ii ◽

Previously Treated

Download Full-text

P5-19-03: Albumin-Bound Paclitaxel (ab-pac) Versus Docetaxel for First-Line Treatment of Metastatic Breast Cancer (MBC): Overall Survival and Safety Analysis of a Randomized Phase II Trial.

10.1158/0008-5472.sabcs11-p5-19-03 ◽

2011 ◽

Cited By ~ 1

Author(s):

WJ Gradishar ◽

D Krasnojon ◽

S Cheporov ◽

AN Makhson ◽

GM Manikhas ◽

...

Keyword(s):

Breast Cancer ◽

Overall Survival ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Line Treatment ◽

First Line ◽

Randomized Phase Ii ◽

First Line Treatment

Download Full-text

P1-14-01: Randomized Phase II Trial of Weekly vs. q 2-Weekly vs. q 3-Weekly Nanoparticle Albumin-Bound Paclitaxel with Bevacizumab as First-Line Therapy for Metastatic Breast Cancer.

10.1158/0008-5472.sabcs11-p1-14-01 ◽

2011 ◽

Author(s):

AD Seidman ◽

AK Conlin ◽

A Bach ◽

A Forero-Torres ◽

G Wright ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii

Download Full-text